Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-09-29
1999-09-14
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514457, A61K 3135
Patent
active
059523743
ABSTRACT:
Methods for inhibiting the development and relieving the symptoms of Alzheimer's disease and related dementias are provided. A phytoestrogenic isoflavone compound is administered to a human predisposed to developing Alzheimer's disease or a related dementia, or having Alzheimer's disease or a related dementia, in an amount effective to inhibit the development or relieve the symptoms of the disease. The phytoestrogenic isoflavone compound is selected from at least one of genistein, genistin, 6'-OMal genistin, 6'-OAc genistin, daidzein, daidzin, 6'-OMal daidzin, 6'-OAc daidzin, glycitein, glycitin, 6'-OMal glycitin, or mixtures thereof. The phytoestrogenic isoflavone compound is effective to up-regulate choline acetyltransferase mRNA and nerve growth factor mRNA.
REFERENCES:
patent: 4841077 (1989-06-01), Ito et al.
patent: 4960908 (1990-10-01), Ito et al.
patent: 5320949 (1994-06-01), Shen
patent: 5352384 (1994-10-01), Shen
patent: 5498631 (1996-03-01), Gorbach et al.
patent: 5589182 (1996-12-01), Tashiro et al.
patent: 5637561 (1997-06-01), Shen et al.
patent: 5637562 (1997-06-01), Shen et al.
patent: 5654011 (1997-08-01), Jackson et al.
patent: 5733926 (1998-03-01), Gorbach
The Flavanoids, Advances in Research Since 1980, ed. J.B. Harbone, Chapman and Hall, Chapter 5, pp. 125-209 (1988).
Long-Term Potentiation in the Hippocampus is Blocked by Tyrosine Kinase Inhibitors, O'Dell, Kandel, and Grant, Nature, vol. 353, pp. 558-560 (Oct. 10, 1991).
Inhibition of Tyrosine Phosphrylation Prevents Delayed Neutronal Death Following Cerebral Ischemia, Kindy, J. Cereb. Blood Flow Metab., vol. 13, No. 3, pp. 372-377 (May 1993).
A Review of the Clinical Effects of Phytoestrogens, Knight and Eden, Obstetrics and Geynecology, vol. 87, No. 5, pp. 897-904 (May 1996).
Symposia: Examining the Benefits of Dietary Phytoestrogens, Inpharma, Dec. 6, 1996.
Inhibition of Tyrosine Phosphorylation Attenuates Amino Acid Neurotransmitter Release From The Ischemic/Reperfused Rat Cerebral Cortex, Phillis, Song, and O'Regan, Neurosci. Letter., vol. 207(3), pp. 151-154 (Apr. 5, 1996).
Phospholipid Metabolism in Alzheimer's Disease and in a Human Cholinergic Cell, Kanfer, Singh, Pettegrew, McCartney, and Sorrentino, J. of Lipid Mediators and Cell Signalling, vol. 14/1-3, pp. 361-363 (1996).
Mechanism by which Ethanol Inhibits Phosphatidylcholine Biosynthesis in Human Leukemic Monocyte-Like U937 Cells, Chu, Cell Biochem. and Function, vol. 12, No. 1, pp. 45-55 (Jan. 1994).
Certain Plant Compounds Can Affect Women's Health, Healthline, pp. 12-14 (Jun. 1992).
Dose-Response Characteristics of Neonatal Exposure to Genistein on Pituitary Responsiveness to Gonadotropin Releasing Hormone and Volume of the Sexually Dimorphic Nucleus of the Preoptic Area SDN-POA in Postpubertal Castrated Female Rats, Faber and Hughes, Reprod. Toxicol., vol. 7(1), pp. 35-39 (1993).
The Effect of Neonatal Exposure to Diethylistilbesterol, Genistein, and Zearlenone on Pituitary Responsiveness and Sexually Dimorphic Nucleus Volume in the Castrated Adult Rat, Faber Hughes, Biology of Reproduction, vol. 45(4), pp. 649-653 (1991).
The Effect of Prenatal Exposure to the Phytoestrogen Genistein on Markers of Sexual Differentiation in Rats, Levy, Faber, Ayyash, and Hughes, Toxicologist, vol. 13(1). p.188 (Mar. 1993).
Commonly Occurring Plant Flavanoids Have Estrogenic Activity, Miksicek, Miksicek, Molecular Pharmacology, vol. 44(1), pp. 37-43 (1993).
Estrogenic Soybean Isoflavones and Chronic Disease: Risks and Benefits, Clarkson, Anthony, and Hughes, Trends in Endocrinology and Metabolism, vol. 6(1), pp. 11-16 (1995).
A Review of Phytoestrogens and Their Effect in Relation to Menopausal Symptoms, Knight et al., Australian J. of Nut. and Dietetics, 53:1, pp. 5-11 (1996).
Adams Michael R.
Anthony Mary Susan
Clarkson, Jr. Thomas Boston
Pan Yuanlong
Waggle Doyle H.
Criares Theodore J.
Protein Technologies International, Inc.
Taylor Richard B.
LandOfFree
Method for inhibiting the development of Alzheimer's disease and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting the development of Alzheimer's disease and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting the development of Alzheimer's disease and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1510246